267 related articles for article (PubMed ID: 12899093)
1. New CA law protects capitated providers against rising specialty pharmacy costs.
Capitation Manag Rep; 2003 Jul; 10(7):102-3. PubMed ID: 12899093
[No Abstract] [Full Text] [Related]
2. Risk contractors take aim at skyrocketing drug costs.
Capitation Manag Rep; 1998 Sep; 5(9):129-34. PubMed ID: 10186047
[No Abstract] [Full Text] [Related]
3. Pharmacy carve-out offers cost control, computer modeling.
Capitation Manag Rep; 2002 Jul; 9(7):103-8, 97. PubMed ID: 12164058
[TBL] [Abstract][Full Text] [Related]
4. Can e-prescribing reduce drug costs under capitation?
Capitation Manag Rep; 2002 Apr; 9(4):58-62, 49. PubMed ID: 12004737
[TBL] [Abstract][Full Text] [Related]
5. Think you can profit with drug risk? Think again!
Capitation Manag Rep; 2000 Jan; 7(1):1-7. PubMed ID: 11183286
[No Abstract] [Full Text] [Related]
6. Can providers survive when accepting pharmacy risk?
Capitation Manag Rep; 1999 Mar; 6(3):33-6. PubMed ID: 10351431
[No Abstract] [Full Text] [Related]
7. Specialty pharmacy management adjusts to new financial realities.
Reinke T
Manag Care; 2013 Apr; 22(4):13-4. PubMed ID: 23678558
[No Abstract] [Full Text] [Related]
8. Does your capitation contract include these 'top 12' clauses?
Capitation Manag Rep; 1999 Mar; 6(3):37-40. PubMed ID: 10351432
[TBL] [Abstract][Full Text] [Related]
9. State legislation inhibiting the operation of managed care pharmacy programs increases costs.
Masso AR; O'Hara J
Benefits Q; 1993; 9(3):46-51. PubMed ID: 10127198
[TBL] [Abstract][Full Text] [Related]
10. Survey highlights trends in managing Medicare drug costs.
Public Sect Contract Rep; 1998 Aug; 4(8):125-7. PubMed ID: 10182909
[TBL] [Abstract][Full Text] [Related]
11. Medicaid programs turn to managed care and capitation to control costs.
Capitation Manag Rep; 2005 Dec; 12(12):140-2, 133. PubMed ID: 16515149
[TBL] [Abstract][Full Text] [Related]
12. The pitfalls and potential of pharmacy risk.
Lawrence J
Manag Care; 1998 May; 7(5):45-6, 51-2. PubMed ID: 10180140
[No Abstract] [Full Text] [Related]
13. Negotiate data guarantees into your next risk contract.
Capitation Manag Rep; 2000 Aug; 7(8):113-6. PubMed ID: 11186755
[No Abstract] [Full Text] [Related]
14. Think twice before assuming risk for pharmacy costs.
Smith DA
Fam Pract Manag; 1999 Jun; 6(6):17-21. PubMed ID: 10558374
[No Abstract] [Full Text] [Related]
15. Study shows increases in drug costs may be justified by improvements in outcomes.
Capitation Rates Data; 2000 Jun; 5(6):65-8. PubMed ID: 11067438
[No Abstract] [Full Text] [Related]
16. Cap for injectables not for the faint of heart.
Capitation Rates Data; 2003 Jul; 8(7):79-81. PubMed ID: 12908211
[No Abstract] [Full Text] [Related]
17. Six questions to ask when eyeing Medicare pharmacy risk.
Public Sect Contract Rep; 1998 Aug; 4(8):117-20. PubMed ID: 10182906
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical cost growth under capitation: a case study.
Chernew M; Cowen ME; Kirking DM; Smith DG; Valenstein P; Fendrick AM
Health Aff (Millwood); 2000; 19(6):266-76. PubMed ID: 11192413
[TBL] [Abstract][Full Text] [Related]
19. Coming to grips with risk-sharing: capitation in the long-term care industry.
Cherney A
Manag Care Q; 1999; 7(1):46-51. PubMed ID: 10350796
[TBL] [Abstract][Full Text] [Related]
20. The top six challenges for capitated providers.
Capitation Manag Rep; 1999 Nov; 6(11):172-4. PubMed ID: 10724584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
